Goodbody Health Limited (GDBYF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 2, 2025
Goodbody Health Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Revenue | 16.47 | 17.06 | 1.99 | 1.45 | 0.26 |
| Revenue Growth (YoY) | 54.36% | 755.37% | 37.58% | 457.50% | - |
| Cost of Revenue | 8.38 | 8.13 | 0.87 | 0.7 | 0.15 |
| Gross Profit | 8.09 | 8.93 | 1.12 | 0.75 | 0.11 |
| Selling, General & Admin | 9.1 | 8.69 | 4.54 | 3.32 | 1.19 |
| Operating Expenses | 9.99 | 10.01 | 6.11 | 4.31 | 1.94 |
| Operating Income | -1.89 | -1.08 | -4.99 | -3.55 | -1.83 |
| Interest Expense | -0 | -0.01 | - | -0.01 | - |
| Interest & Investment Income | - | - | 0.04 | - | - |
| Currency Exchange Gain (Loss) | -0.86 | -0.49 | -0.05 | - | - |
| Other Non Operating Income (Expenses) | -0.21 | 0.03 | 0.17 | - | - |
| EBT Excluding Unusual Items | -2.97 | -1.56 | -4.84 | -3.56 | -1.83 |
| Merger & Restructuring Charges | - | - | - | - | -0.04 |
| Impairment of Goodwill | -0.14 | -0.14 | - | - | - |
| Gain (Loss) on Sale of Investments | 0 | 0 | -0.03 | -0.14 | 0.01 |
| Asset Writedown | -0.75 | -0.75 | 0.08 | -0.09 | - |
| Other Unusual Items | 0.2 | 0.2 | - | - | - |
| Pretax Income | -3.66 | -2.25 | -4.79 | -3.8 | -1.86 |
| Income Tax Expense | 0.07 | 0.07 | -0.13 | - | - |
| Net Income | -3.72 | -2.31 | -4.66 | -3.8 | -1.86 |
| Net Income to Common | -3.72 | -2.31 | -4.66 | -3.8 | -1.86 |
| Shares Outstanding (Basic) | 36 | 35 | 16 | 8 | 36 |
| Shares Outstanding (Diluted) | 36 | 35 | 16 | 8 | 36 |
| Shares Change (YoY) | 10.29% | 113.10% | 104.07% | -77.77% | - |
| EPS (Basic) | -0.10 | -0.07 | -0.29 | -0.48 | -0.05 |
| EPS (Diluted) | -0.10 | -0.07 | -0.29 | -0.48 | -0.05 |
| Free Cash Flow | -0.99 | 1.61 | -2.56 | -3.14 | -1.71 |
| Free Cash Flow Per Share | -0.03 | 0.05 | -0.16 | -0.39 | -0.05 |
| Gross Margin | 49.13% | 52.35% | 56.35% | 52.03% | 42.31% |
| Operating Margin | -11.49% | -6.35% | -250.16% | -245.12% | -703.46% |
| Profit Margin | -22.61% | -13.57% | -233.61% | -261.99% | -715.00% |
| Free Cash Flow Margin | -6.04% | 9.46% | -128.32% | -216.51% | -658.46% |
| EBITDA | -1.58 | -0.23 | -4.67 | -3.38 | -1.72 |
| EBITDA Margin | -9.57% | -1.34% | -234.30% | -233.28% | - |
| D&A For EBITDA | 0.32 | 0.85 | 0.32 | 0.17 | 0.11 |
| EBIT | -1.89 | -1.08 | -4.99 | -3.55 | -1.83 |
| EBIT Margin | -11.49% | -6.35% | -250.16% | -245.12% | - |
Source: S&P Capital IQ. Standard template. Financial Sources.